FILTER
LATEST INTERVIEWS
Jay Chmelauskas
CEO AND PRESIDENT, CAMINO CORPORATION
"The consensus is that high-risk capital investment is crucial for making significant discoveries."
Pablo Rosales
CEO, TARPULIN
"Approximately 40% of our modular construction production occurs in our local factory in Chile."
Simon Askey-Doran
GENERAL MANAGER – BUSINESS DEVELOPMENT ADVISORY, RPM GLOBAL
"With the expanding transport infrastructure throughout Mongolia, projects that may have been unattractive 15 years ago are being viewed with a new perspective."
Petr Osvald
GENERAL MANAGER, SRK CONSULTING (MONGOLIA)
"Our vision is to assist both local project owners and investors and assist Mongolia in developing successful projects to raise the profile of the country as a preferred global mining destination."
Trevor Caswell
CHAIRMAN, PHARMA.AERO
"We now offer an open platform for life sciences companies to have conversations around priorities in their field and discuss challenges in the supply chain."
Don Duval
CEO, NORCAT
"NORCAT is the only innovation centre in the world that has an operating mine designed to enable start-ups, SMEs, and international companies to develop, test and demonstrate emerging technologies."
Olumide Esan
PARTNER AND ENERGY & CHEMICALS LEADER, DELOITTE NIGERIA
"The energy transition can only be funded by big oil, as they are the only players who can balance the low returns of renewables projects with their high earning fossil fuel projects."
Ron White
DIRECTOR - SALES AND MARKETING, 3D-P
"Our commitment to being OEM and technology agnostic sets us apart, enabling collaboration with diverse technologies."
Travis Deti
EXECUTIVE DIRECTOR, WYOMING MINING ASSOCIATION (WMA)
"Wyoming is strategically positioned to address the geopolitical challenges affecting critical minerals, particularly in the uranium sector."
Greg Smith
PRESIDENT AND CEO, EQUINOX GOLD
"When operating at capacity, Greenstone will be our largest and lowest-cost mine, so we are really at a pivotal point in the company’s history."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
